Tad Heitmann

Tad Heitmann is a corporate communications, marketing, and public relations leader with extensive experience in the life sciences and healthcare sectors. They served as Vice President of Corporate Communications and Investor Relations at Nexell Therapeutics and held prominent roles at various firms, including BioComm Network, Inc. and Aerie Pharmaceuticals, where they led communications strategies. Additionally, they contributed to the integration of Aerie into Alcon as a Marketing and Communications Executive, showcasing their expertise in delivering impactful messaging. Tad holds a degree from Pepperdine University, further underscoring their commitment to professional development and leadership in the field.